Photoantimicrobials-are we afraid of the light?

Wainwright, Mark and Maisch, Tim and Nonell, Santi and Plaetzer, Kristjan and Almeida, Adelaide and Tegos, George P. and Hamblin, Michael R. (2017) Photoantimicrobials-are we afraid of the light? LANCET INFECTIOUS DISEASES, 17 (2). E49-E55. ISSN 1473-3099, 1474-4457

Full text not available from this repository. (Request a copy)

Abstract

Although conventional antimicrobial drugs have been viewed as miraculous cure-alls for the past 80 years, increasing antimicrobial drug resistance requires a major and rapid intervention. However, the development of novel but still conventional systemic antimicrobial agents, having only a single mode or site of action, will not alleviate the situation because it is probably only a matter of time until any such agents will also become ineffective. To continue to produce new agents based on this notion is unacceptable, and there is an increasing need for alternative approaches to the problem. By contrast, light-activated molecules called photoantimicrobials act locally via the in-situ production of highly reactive oxygen species, which simultaneously attack various biomolecular sites in the pathogenic target and therefore off er both multiple and variable sites of action. This non-specificity at the target circumvents conventional mechanisms of resistance and inhibits the development of resistance to the agents themselves. Photoantimicrobial therapy is safe and easy to implement and, unlike conventional agents, the activity spectrum of photoantimicrobials covers bacteria, fungi, viruses, and protozoa. However, clinical trials of these new, truly broad-spectrum, and minimally toxic agents have been few, and the funding for research and development is almost non-existent. Photoantimicrobials constitute one of the few ways forward through the morass of drug-resistant infectious disease and should be fully explored. In this Personal View, we raise awareness of the novel photoantimicrobial technologies that off er a viable alternative to conventional drugs in many relevant application fields, and could thus slow the pace of resistance development.

Item Type: Article
Uncontrolled Keywords: POTENTIATE ANTIMICROBIAL PHOTOINACTIVATION; PHOTODYNAMIC THERAPY; IN-VITRO; STAPHYLOCOCCUS-AUREUS; ACNE TREATMENT; INACTIVATION; RESISTANCE; PHOTOSENSITIZER; BACTERIA; ANTIBIOTICS;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 14 Dec 2018 13:01
Last Modified: 14 Feb 2019 10:43
URI: https://pred.uni-regensburg.de/id/eprint/410

Actions (login required)

View Item View Item